Evaluation of Anterior Tibial Knee Translation in Healthy Women With and Without Hormone Therapy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-40
SponsorCentre Hospitalier Universitaire de Nice
About this trial
Women are recognized as being at greater risk of ACL injury, with a risk 6 times higher than that of men. Hyperlaxity is a risk factor for ACL injury, but the pathophysiological basis for this is poorly studied. Hormonal impregnation and certain periods of the menstrual cycle (ovulatory phase) are risk factors for ACL injury. It therefore seems interesting to study the influence of hormonal impregnation on ligament laxity. To date, to our knowledge, no study has investigated such a relationship.
Eligibility criteria
Qualifiers
Female between 18 and 40 years of age;
No history of surgery on the 2 lower limbs;
No change in contraceptive method in the last 6 months;
Signature of informed consent ;
Disqualifiers
Pregnancy or breastfeeding (check with urine pregnancy test);
Menopause;
Surgery: tubal ligation, oophorectomy, adnexectomy, hysterectomy;
History of inflammatory joint disease, systemic or localized to the knee;
Trial design
Treatments tested in this trial
- Questionnaire
- Beighton test
- Lachman Test
Treatment groups
90 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov